From the age of 45, there is a continuous decrease of the first symptoms – in the age group of 64 years or more, the incidence is 0.3%. From then on, however, the medical consultation lasted for about four years – although 24.3% of the respondents sought a doctor between one and six months after the initial symptoms and 12.9% within a month, many revealed that they had expected several years, some even more than ten (14.6%).
"It is also in the 25-34 years that the greatest number of diagnoses are recorded, the majority (65.6%) made by a rheumatology specialist," says the specialist. According to the participants' responses, the sacroiliac joints (77.4%), cervical spine (74.3%), hips (71.5%), dorsal and lumbar spine (47.5%), knees %), shoulders (42.4%) and hand joints (40.1%) are the most affected parts of the body affected.
The most effective drugs and therapies
The BASDAI score, which measures morning stiffness ranging from 0 (= good) to 10 (= bad) is 5.5, with a mean morning stiffness from the wake of 50 minutes (7.3% feel nothing, the others vary between 1-30 minutes and 2 hours or more). Anti-inflammatory drugs (65%), antirheumatics (35.3%) and biological / biosimilars (22.9%) are among the drugs taken by the respondents, the latter showing the best effects on improving the quality of life (work, mood, leisure and leisure time, social relations, sport and physical activity, independence, sexual activity – on a scale of 0 to 10, are between 5.3 and 6.4). Anti-inflammatory and antirheumatic drugs are respectively between 3.5-4.6 and 3.5-4.4).
Respondents also reported that they had made a large appeal to the National Health Service because of the AS: 85% for consultations, 74% for exams, 48% for the emergency department and 8% were hospitalized. 43.2% of the patients had no health subsystem, 29.7% had health insurance and 16.1% had ADSE – a minority had SAMS, ADM or others.
The study also reveals that many of the patients with AD suffer simultaneously from other illnesses, such as anxiety, depression, fibromyalgia, sleep disorders and especially arterial hypertension. In the case of anxiety and depression, 54.4% reported being moderately anxious or depressed the previous year as a result of Ankylosing Spondylitis.
The impact of AD in patients extends in the medium and long term, also shows that the possibility of becoming incapacitated (32.5%) or dependent on third parties (12.4%) and increasing pain (8 , 8%) top the list of fears expressed by the respondents. Regarding the expectations regarding the treatment of Spondylitis, 44.6% do not know / do not respond, but 10.5% expressed hope for cure, 8.2% for pain reduction and 7.9% for keeping the disease under control.